Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Drugs
Published in: Drugs 12/2018

01-08-2018 | Correction

Correction to: Anlotinib: First Global Approval

Author: Yahiya Y. Syed

Published in: Drugs | Issue 12/2018

Login to get access

Excerpt

Page 1058, Section 2.2 Pharmacokinetics …
Metadata
Title
Correction to: Anlotinib: First Global Approval
Author
Yahiya Y. Syed
Publication date
01-08-2018
Publisher
Springer International Publishing
Published in
Drugs / Issue 12/2018
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.1007/s40265-018-0961-z

Other articles of this Issue 12/2018

Drugs 12/2018 Go to the issue

Correction

Correction to: Andexanet Alfa: First Global Approval

Adis Drug Evaluation

Alectinib: A Review in Advanced, ALK-Positive NSCLC

Adis Drug Evaluation

Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections

Leading Article

Adult-Onset Still’s Disease: Molecular Pathophysiology and Therapeutic Advances

Review Article

Perioperative Use of Intravenous Lidocaine

Review Article

Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option